MINNEAPOLIS, Sept. 30 /PRNewswire-FirstCall/ -- Biotel Inc. (OTC
Bulletin Board: BTEL) announced results for the year ended June 30, 2008,
with net earnings of $666,000, or $0.23 per diluted share, on revenues of
$11,495,000. This compares to net earnings of $520,000, or $0.19 per share,
on revenues of $11,233,000 for the prior year. For its fourth quarter, the
company reported net earnings of $191,000, or $0.07 per diluted share, on
revenues of $3,187,000. This compares to net earnings of $221,000, or $0.08
per diluted share, on revenues of $3,115,000 in the fourth quarter of 2007.
Highlights for the quarter and year are as follows:
-- Sixth year in a row of profitable growth.
-- Record sales for the fourth quarter and year
-- Net income for the year up 28.1 percent over 2007
-- Gross margin for the year was 44.4% versus 42.6% last year
"Biotel achieved a record fiscal year in revenues and earnings with a
strong improvement in the fourth quarter over the third quarter," Biotel
President and CEO Steve Springrose said. "Our Braemar Holter devices, event
recorders, liposuction and other medical devices made strong revenue
contributions, and our Agility 24/7 cardiac monitoring services continued
to make very strong year over year gains. The highlight of the quarter was
the introduction of our new ER920W cardiac arrhythmia monitor, our first
entry into the high potential wireless market. Very importantly, we have
already received FDA 510(k) approval of our next generation wireless
monitor employing 'Fusion' technology, scheduled for product introduction
early in calendar 2009. Biotel serves as a development partner to medical
corporations seeking new devices and clinical research services."
3 months ended 3 months ended %
June 30, 2008 June 30, 2007 Change
Revenues $3,187,000 $3,115,00
|SOURCE Biotel Inc.|
Copyright©2008 PR Newswire.
All rights reserved